Diabetes Care, Vol 22, Issue 2 253-261, Copyright © 1999 by American Diabetes Association

ARTICLES

Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes

A Doria, Y Yang, M Malecki, S Scotti, J Dreyfus, C O'Keeffe, T Orban, JH Warram and AS Krolewski
Section on Genetics, Joslin Diabetes Center, Boston, MA 02215, USA. adoria@joslin.harvard.edu

OBJECTIVE: To investigate whether there are forms of early-onset autosomal-dominant type 2 diabetes that are distinct from typical maturity-onset diabetes of the young (MODY) and to characterize their phenotypic characteristics. RESEARCH DESIGN AND METHODS: The study included 220 affected subjects from 29 families in which early-onset type 2 diabetes occurred in multiple generations and was not linked to known MODY genes (MODY gene-negative families). All individuals underwent an oral glucose tolerance test and other clinical measurements aimed at investigating the underlying metabolic defect and the presence of diabetic complications. For comparison, 79 affected carriers of MODY3 (hepatocyte nuclear factor [HNF]-1 alpha) mutations were similarly examined. RESULTS: Subjects from MODY gene-negative pedigrees were diagnosed with diabetes at an older age (36 +/- 17 vs. 21 +/- 10 years, P = 0.0001) and were more frequently obese (52 vs. 18%, P = 0.0001) than MODY3 individuals. MODY gene-negative patients who were insulin treated required more exogenous insulin than did MODY3 subjects (0.7 +/- 0.4 vs. 0.45 +/- 0.2 U.kg-1.day-1, P = 0.04), despite similar C-peptide levels. Among subjects not treated with insulin, MODY gene-negative subjects had significantly higher serum insulin levels, both fasting (16.5 +/- 15 vs. 6.5 +/- 5 microU/ml, P = 0.027) and 2 h after a glucose load (53 +/- 44 vs. 11 +/- 10, P = 0.002). They also had higher serum triglycerides (P = 0.02), higher cholesterol levels (P = 0.02), more hypertension (P = 0.0001), and more nephropathy (P = 0.001). Differences persisted when families were matched for age at diagnosis. CONCLUSIONS: Our findings indicate the existence of forms of early-onset autosomal-dominant type 2 diabetes that are distinct from MODY and are frequently characterized by insulin resistance, similar to later-onset type 2 diabetes. Because of the Mendelian pattern of inheritance, the goal of identifying the genes involved in these forms of diabetes appears to be particularly feasible.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S.-H. Kim, X. Ma, T. Klupa, C. Powers, M. Pezzolesi, J. H. Warram, S. S. Rich, A. S. Krolewski, and A. Doria Genetic Modifiers of the Age at Diagnosis of Diabetes (MODY3) in Carriers of Hepatocyte Nuclear Factor-1{alpha} Mutations Map to Chromosomes 5p15, 9q22, and 14q24 Diabetes, August 1, 2003; 52(8): 2182 - 2186. [Abstract] [Full Text] [PDF]

				T. M. Frayling, C. M. Lindgren, J. C. Chevre, S. Menzel, M. Wishart, Y. Benmezroua, A. Brown, J. C. Evans, P. S. Rao, C. Dina, et al. A Genome-Wide Scan in Families With Maturity-Onset Diabetes of the Young: Evidence for Further Genetic Heterogeneity Diabetes, March 1, 2003; 52(3): 872 - 881. [Abstract] [Full Text] [PDF]

				T. Klupa, J. H. Warram, A. Antonellis, M. Pezzolesi, M. Nam, M. T. Malecki, A. Doria, S. S. Rich, and A. S. Krolewski Determinants of the Development of Diabetes (Maturity-Onset Diabetes of the Young-3) in Carriers of HNF-1{alpha} Mutations: Evidence for parent-of-origin effect Diabetes Care, December 1, 2002; 25(12): 2292 - 2301. [Abstract] [Full Text] [PDF]

				C. M. Lindgren, E. Widen, T. Tuomi, H. Li, P. Almgren, T. Kanninen, O. Melander, J. Weng, M. Lehto, and L. C. Groop Contribution of Known and Unknown Susceptibility Genes to Early-Onset Diabetes in Scandinavia: Evidence for Heterogeneity Diabetes, May 1, 2002; 51(5): 1609 - 1617. [Abstract] [Full Text] [PDF]

				C. Menzaghi, N. Plengvidhya, X. Ma, J. H. Warram, S. E. Shoelson, and A. Doria COMMENT: Genetic Variability in Insulin Action Inhibitor Ikk{beta} (IKBKB) Does Not Play a Major Role in the Development of Type 2 Diabetes J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1894 - 1897. [Abstract] [Full Text] [PDF]

				S.-H. Kim, J. H. Warram, A. S. Krolewski, and A. Doria Mutation Screening of the Neurogenin-3 Gene in Autosomal Dominant Diabetes J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2320 - 2322. [Abstract] [Full Text]

				M. C.Y. Ng, S.-C. Lee, G. T.C. Ko, J. K.Y. Li, W.-Y. So, Y. Hashim, A. H. Barnett, I. R. Mackay, J. A.J.H. Critchley, C. S. Cockram, et al. Familial Early-Onset Type 2 Diabetes in Chinese Patients: Obesity and genetics have more significant roles than autoimmunity Diabetes Care, April 1, 2001; 24(4): 663 - 671. [Abstract] [Full Text]

				C. A. Aguilar-Salinas, E. Reyes-RodrÍguez, Ma. L. Ordóñez-Sánchez, M. A. Torres, S. Ramírez-Jiménez, A. Domínguez-López, J. R. MartÍnez-Francois, Ma. L. Velasco-Pérez, M. Alpizar, E. GarcÍa-GarcÍa, et al. Early-Onset Type 2 Diabetes: Metabolic and Genetic Characterization in the Mexican Population J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 220 - 226. [Abstract] [Full Text]

				A. Bektas, J. N. Hughes, J. H. Warram, A. S. Krolewski, and A. Doria Type 2 Diabetes Locus on 12q15: Further Mapping and Mutation Screening of Two Candidate Genes Diabetes, January 1, 2001; 50(1): 204 - 208. [Abstract] [Full Text]

				H. Nishigori, H. Tomura, N. Tonooka, M. Kanamori, S. Yamada, K. Sho, I. Inoue, N. Kikuchi, K. Onigata, I. Kojima, et al. Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects PNAS, January 16, 2001; 98(2): 575 - 580. [Abstract] [Full Text] [PDF]